SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its third quarter ended September 30, 2009 after the market closes on Wednesday, October 28, 2009.
Alan D. Gold, Chairman and Chief Executive Officer, and Kent Griffin, President and Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, October 29, 2009 to discuss the company's financial results and operations for the quarter.
The call will be open to all interested investors either through a live audio web cast at the Investor Relations section of the company's web site at www.biomedrealty.com and at www.earnings.com, or live by calling 866.730.5763 (domestic) or 857.350.1587 (international) with call ID number 77837912. The call will be archived for 30 days on both web sites. A telephone playback of the conference call will also be available from 1:00 p.m. Pacific Time on Thursday, October 29, 2009 until midnight Pacific Time on Tuesday, November 3, 2009 by calling 888.286.8010 (domestic) or 617.801.6888 (international) and using access code 45309153.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 69 properties, representing 114 buildings with approximately 10.5 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.
SOURCE BioMed Realty Trust, Inc.
Rick Howe, Director, Corporate Communications of BioMed Realty Trust, Inc., +1-858-207-5859